Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 49,652Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 13AMGEN CANADA INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : SOLUTION

Dosage Strength : 100MCG/ML

Packaging : 0.4ML(4 SYRINGES)

Approval Date :

Application Number : 2391740

Regulatory Info : Schedule D

Registration Country : Canada

blank

02

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : SOLUTION

Dosage Strength : 100MCG/ML

Packaging : 4

Approval Date :

Application Number : 2391759

Regulatory Info : Schedule D

Registration Country : Canada

blank

03

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : SOLUTION

Dosage Strength : 200MCG/ML

Packaging : 4

Approval Date :

Application Number : 2391767

Regulatory Info : Prescription

Registration Country : Canada

blank

04

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : SOLUTION

Dosage Strength : 200MCG/ML

Packaging : Apr-16

Approval Date :

Application Number : 2391775

Regulatory Info : Prescription

Registration Country : Canada

blank

05

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : SOLUTION

Dosage Strength : 200MCG/ML

Packaging : 4 SYRINGES/CARTON

Approval Date :

Application Number : 2391783

Regulatory Info : Prescription

Registration Country : Canada

blank

06

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : SOLUTION

Dosage Strength : 500MCG/ML

Packaging :

Approval Date :

Application Number : 2391791

Regulatory Info : Prescription

Registration Country : Canada

blank

07

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : SOLUTION

Dosage Strength : 500MCG/ML

Packaging : 2

Approval Date :

Application Number : 2391805

Regulatory Info : Schedule D

Registration Country : Canada

blank

08

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : SOLUTION

Dosage Strength : 500MCG/ML

Packaging : 4

Approval Date :

Application Number : 2391821

Regulatory Info : Schedule D

Registration Country : Canada

blank

09

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : SOLUTION

Dosage Strength : 25MCG/ML

Packaging :

Approval Date :

Application Number : 2392313

Regulatory Info : Prescription

Registration Country : Canada

blank

10

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

DARBEPOETIN ALFA

Brand Name : ARANESP

Dosage Form : SOLUTION

Dosage Strength : 40MCG/ML

Packaging : 4

Approval Date :

Application Number : 2392321

Regulatory Info : Schedule D

Registration Country : Canada

blank